Autologous Cell Therapy Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)

The report covers Autologous Cell Therapy Market Trends & Companies and the Market is Segmented by Therapy (Autologous Stem Cell Therapy and Autologous Cellular Immunotherapies), Application (Oncology, Musculoskeletal Disorder, Blood Disorder, Autoimmune Disease and Others), Source (Bone Marrow, Epidermis and Others), End User (Hospitals, Research Centers and Others), and Geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America). The market provides the value (in USD million) for the above-mentioned segments.

Autologous Cell Therapy Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)

Autologous Cell Therapy Industry Overview

The autologous cell therapy market is moderately competitive and consists of several major players. In terms of market share, few of the major players are currently dominating the market.  And some prominent players are vigorously making acquisitions and joint ventures with the other companies to consolidate their market positions across the globe. Some of the companies which are currently dominating the market are Vericel Corporation, Pharmicell Co., Inc., Holostem Terapie Avanzate S.r.l., Lineage Cell Therapeutics, Inc., and Opexa Therapeutics.

Autologous Cell Therapy Market Leaders

  1. Vericel Corporation

  2. Pharmicell Co., Inc.

  3. Holostem Terapie Avanzate S.r.l.

  4. Opexa Therapeutics

  5. Lineage Cell Therapeutics, Inc.

  6. *Disclaimer: Major Players sorted in no particular order
Autologous - MC.jpg

Autologous Cell Therapy Market Report Snapshots

80% of our clients seek made-to-order reports. How do you want us to tailor yours?